Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
1.210
+0.020 (1.68%)
At close: Apr 18, 2024, 12:00 AM
1.170
-0.040 (-3.31%)
After-hours: Apr 18, 2024, 4:00 PM EDT
Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $8.01 million. The enterprise value is $4.16 million.
| Market Cap | 8.01M |
| Enterprise Value | 4.16M |
Important Dates
The last earnings date was Monday, April 1, 2024, before market open.
| Earnings Date | Apr 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 6.62 million shares outstanding.
| Shares Outstanding | 6.62M |
| Owned by Insiders (%) | 17.91% |
| Owned by Institutions (%) | 1.61% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95
| Current Ratio | 0.95 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,281.40%.
| Return on Equity (ROE) | -1,281.40% |
| Return on Assets (ROA) | -110.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.11M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.16% in the last 52 weeks. The beta is 0.97, so AKTX's price volatility has been similar to the market average.
| Beta (1Y) | 0.97 |
| 52-Week Price Change | -72.16% |
| 50-Day Moving Average | 1.94 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 29.08 |
| Average Volume (30 Days) | 12,669 |
Short Selling Information
| Short Interest | 10,516 |
| Short Previous Month | 5,949 |
| Short % of Shares Out | 0.19% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.81M |
| Pretax Income | -10.01M |
| Net Income | -10.01M |
| EBITDA | -10.00M |
| EBIT | -10.01M |
| Earnings Per Share (EPS) | -$2.04 |
Balance Sheet
The company has $3.85 million in cash and no debt, giving a net cash position of $3.85 million or $0.58 per share.
| Cash & Cash Equivalents | 3.85M |
| Total Debt | n/a |
| Net Cash | 3.85M |
| Net Cash Per Share | $0.58 |
| Equity / Book Value | -229,000 |
| Book Value Per Share | -0.03 |
| Working Capital | -243,000 |
Cash Flow
| Operating Cash Flow | -16.43M |
| Capital Expenditures | n/a |
| Free Cash Flow | -16.43M |
| FCF Per Share | -$3.36 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -82.69% |
| Shareholder Yield | -82.69% |
| Earnings Yield | -124.99% |
| FCF Yield | -205.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 17, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |